c ebpβ-lip drug Facts Continuous Activation of C/EBPβ Transcription – A screening strategy for the
A screening strategy for the discovery of drugs that reduce C EBP LIP translation with potential calorie restriction mimetic properties Scientific Reports C EBP beta Antibody Cell Signaling Technology C EBP sustains the oncogenic program of AML cells by cooperating with MYB and co activator p300 in a transcriptional module Experimental Hematology CCAAT Enhancer Binding Proteins in Fibrosis: Complex Roles Beyond Conventional Understanding Research
Pay in 4 interest-free payments of $6.05 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9


